What is the most appropriate first-line pharmacological management for the motor complications associated with Parkinson’s disease? By pa2be admin|2020-11-12T20:26:11+00:00November 12th, 2020| Share This Post With Others! facebooktwitterlinkedinwhatsapppinterestEmail